Subjective idiopathic tinnitus. A review of clinical experience 1979-2005

Otorinolaringologia

Volumn 55, Issue 1, 2005, Pages 23-33

  Shulman, A ^a   Goldstein, B ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Receptor targeted therapy; Tinnitogenesis; Tinnitology; Tinnitus, diagnosis; Tinnitus, etiology; Tinnitus, therapy

Indexed keywords

4 AMINOBUTYRIC ACID; ANESTHETIC AGENT; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTIOXIDANT; CARBAMAZEPINE; CHLORPHENIRAMINE; CLONAZEPAM; DEXCHLORPHENIRAMINE; GABAPENTIN; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; LIDOCAINE; PENTOXIFYLLINE; PRIMIDONE; PROCAINAMIDE; SALICYLIC ACID; SEDATIVE AGENT; TOCAINIDE;

ACUPUNCTURE; AUDIOLOGY; COGNITIVE THERAPY; DIAGNOSTIC ACCURACY; ELECTRODIAGNOSIS; ELECTROENCEPHALOGRAPHY; FEEDBACK SYSTEM; HUMAN; NOISE REDUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OTOTOXICITY; PREVALENCE; PSYCHOTHERAPY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOMATOLOGY; TINNITUS; TREATMENT OUTCOME;

EID: 22144481358     PISSN: 00264938     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Shulman A, Tonndorf J, Feldmann H, Aran JA, Vernonet J. Tinnitus diagnosis treatment. Philadelphia: Lea B Febiger; 1991.
2. Shulman A. Medical audiological evaluation of the tinnitus patient. Semin Hear 1987;8:7-14.
3. Insights In Otolaryngology (Seminars 1979). Philadelphia: Mosby-Year Book, Inc.; 1990.
4. Shulman A, Goldstein B. Medical significance tinnitus. Int Tinnitus J 1997;3:45-50.
5. Shulman A, Strashun AM, Goldstein BA, Afryie MO. Neurospect Cerebral Blood Flow Studies in Patients with a central type Tinnitus. Preliminary Study. Transactions 4th International Tinnitus Seminar. Amsterdam: Kugler Public.; 1991.p.211-5.
6. Shulman A, Strashun AM, Afriyie M, Aronson F, Abel W, Goldstein B. SPECT Imaging of brain and tinnitus - neurotology neurologic implications. Int Tinnitus J 1995;1:13-29.
7. Shulman A. Stress Model for tinnitus. Presentation International Tinnitus Group. Washinton DC; 1992.
8. Shulman A. Stress model for tinnitus. Neurotol Newslett 1998;3:53-7.
9. Shulman A. A final common pathway for tinnitus - medial temporal lobe system. Int Tinnitus J 1995;1:115-26.
10. Shulman A, Strashun AM. Descending auditory system/cerebellum/tinnitus. Int Tinnitus J 1999;5:92-106.
11. Shulman A, Strashun AM, Seibyl JP, Daftery A, Goldstein B. Benzodiazepine receptor deficiency and tinnitus. Int Tinnitus J 2000;6:98-111.
12. Shulman A, Strashun AM, Goldstein BA. GABA A-benzodiazepine-chloride receptor-targeted therapy for tinnitus control: preliminary report. Int Tinnitus J 2002;8:30-6.
13. Daftary A, Shulman A, Strashun AM, Gottshalk C, Zoghbi S, Seibyl JP. Benzodiazepine receptor distribution in severe disabling tinnitus. Int Tinnitus J 2004;10:17-23.
14. Shulman A, Strashun AM, Avitable MJ, Lenhardt ML, Goldstein B. Ultrahigh frequency acoustic stimulation and tinnitus control-A PET Study. Int Tinnitus J 2004;10:113-26.
15. Itard JMG. Traités des maladies de l'oreille et de l'audition. Paris: Méquignon-Marvis; 1821.
16. Shulman A. Subjective idiopathic tinnitus clinical types: a system of nomenclature and classification. In: Feldmann H, editor. Proceedings. Third International Tinnitus Seminar. Karlsruhe: Harsch Verlag; 1987. p. 136-41.
17. Shulman A. Subclinical tinnitus: non-auditory tinnitus. J Laryngol Otol Suppl 1984;9:77-9.
18. Jannetta PJ. Neurovascular compression in cranial nerve and systemic disease. Ann Surg 1981;192:518-25.
19. Shulman A, Seitz M. Central tinnitus - diagnosis/treatment. Observations simultaneous binaural auditory brain stem responses with monaural stimulation in the tinnitus patient. Laryngoscope 1981;91:2025-35.
20. Middlebrooks JC. The acquisitive auditory cortex. Nat Neurosci 2003;6:1122-3.
21. Fritz J, Shamma S, Elhilali M, Klein D. Rapid task-related plasticity of spectrotemporal receptive fields in primary auditory cortex. Nat Neurosci 2003;6:1216-23.
22. Jeanmonod D, Magnin M, Marel A. Low threshold calcium spike bursts in human thalamus. Brain 1996;119:363-75.
23. Shulman A. Tinnitology, tinnitogenesis, nuclear medicine, and tinnitus patients. Int Tinnitus J 1998;4:102-8.
24. Shulman A. Neuroprotective drug therapy: a medical and pharmacological treatment for tinnitus control. Int Tinnitus J 1997;3:77-94.
25. Shulman A. Tinnitus: diagnosis and treatment. Hear Aid J 1979;32-34.
26. Shulman A. Clinical classification subjective idiopathic tinnitus. J Laryngol Otol Suppl 1981;4:102-6.
27. Shulman A. Neurotologic classification and tinnitus. J Laryngol Otol Suppl 1984;9:147-9.
28. Vernon J, Schleuning A. A new management. Laryngoscope 1978; 38:413-9.
29. Shulman A, Tonndorf J, Feldmann H, Aran JA, Vernonet J. Tinnitus diagnosis treatment. Philadelphia: Lea B Febiger; 1991.p.319-21.
30. Feldmann H. Homolateral and contralateral masking of tinnitus. J Laryngol Otol Suppl 1981;4:60-70.
31. Goldstein B, Shulman A. Tinnitus outcome profile and tinnitus control. Int Tinnitus J 2003;9:26-31.
32. Shulman A, Goldstein B. Quantitative electroencephalography: preliminary report- tinnitus. Int Tinnitus J 2002;8:77-86.
33. Claussen CF. Craniocorpography (CCG) a simple photo-optic registration method for vestibulo-spinal reactions. Z Laryngol Rhinol Otol 1970;49:634-9. German.
34. Goldstein B, Shulman A. Tinnitus - hyperacusis and the loudness discomfort test: a preliminary report. Int Tinnitus J 1996;2:83-9.
35. Shulman A. Secondary endolymphatic hydrops-tinnitus. Otolaryngol Head Neck Surg 1991;104:146-7.
36. Lenhardt ML, Skellett R, Wang P, Clarke AM. Human ultrasonic speech perception. Science 1991;253:82-5.
37. Goldstein BA, Shulman A, Lenhardt ML, Richards DG, Madsen AG, Guinta R. Long-term inhibition of tinnitus by UltraQuiet therapy: Preliminary report. Int Tinnitus J 2001;7:122-7.
38. Lenhardt ML, Goldstein BA, Shulman A, Guinta R. Use of high frequency and muscle vibration in the treatment of tinnitus. Int Tinnitus J 2003;9:32-6.
39. Kitahara M. Combined treatment for tinnitus. In: Kitahara M, editor. Tinnitus, pathophysiology and management. Tokyo: Igaku-Shoin; 1988.p.107-17.
40. Shulman A. Medical Methods, Drug Therpy, and Tinnitus Control Strategies. In: Shulman A, Tonndorf J, Feldmann H, Aran JA, Vernonet J, editors. Tinnitus diagnosis treatment. Philadelphia, PA: Lea and Febiger; 1991.p.453-89.
41. Shulman A. A receptor targeted therapy for a predominantly central type tinnitus. Presentation AAO HNS Annual Meeting 2001, September 11, Denver, CO.
42. Shulman A. GABA-A receptor targeted therapy for a predominantly central type tinnitus. Presentation. Charles University, Department Otolaryngology, Prague, Czech Republic, March 30, 2004.
43. Shulman A. TMJ and tinnitus - a migraine phenomenon? A neural hypothesis. In: Claussen CF, Constantinescu L, Kirtane MV, Schneider D, editors. Proceedings of the NES. Intl. Congress Series 1133. Excerpta Medica. Amsterdam: Elsevier Science; 1996.p.113-9.
44. Sakata E, Itoh A, Ohtsu K et al. Treatment of cochlear tinnitus. Effectg of transtympanic infusion with dexamethasone fluid. Audiology (Jpn) 1983;26:148-51.
45. Shulman A, Goldstein B. Intratympanic drug therapy with steroids for tinnitus control: a preliminary report. Int Tinnitus J 2000;6: 10-20.
46. Shulman A, Goldstein B. Tinnitus masking - a longitudinal study of efficacy diagnosis: treatment 1977-1986. In: Feldmann H, editor. Proceedings, Third International Tinnitus Seminar. Karlsruhe: Harsch Verlag; 1987.p.251-6.
47. Goldstein B, Shulman A. Tinnitus masking. A longitudinal study 1987-1994. In: Reich GE, Vernon JA, editors. Proceedings of the Fifth International Tinnitus Seminar 1995. Portland, OR: American Tinnitus Association; 1996.p.315-32.
48. Jastreboff PJ, Hazell JWP. A neurophysiological approach to tinnitus: clinical implications. Br J Audiol 1993;27:1-11.
49. Shulman A. External electrical stimulation in tinnitus Control. Am J Otol 1985;6:110-5.
50. Shulman A. External electrical tinnitus suppression: a review. 1983-1985. Am J Otol 1987;8:479-84.
51. Shulman A. Electrodiagnostics, electrotherapeutics, and other approaches to the management of tinnitus. In: AAO-HNS Instructional Courses. St. Louis: C.V. Mosby; 1989.p.137.
52. Steenerson RL, Cronin GW. Electrical stimulation in the treatment of tinnitus. In: Reich GE, Vernon JA, editors. Proceedings of the Fifth International Tinnitus Seminor 1995. Portland, OR: American Tinnitus Association; 1996.p.353-6.
53. Rubinstein JT, Tyler RS, Johnson A, Brown CJ. Electrical suppression tinnitus with high rate pulse trains. Otol Neurotol 2003;24: 478-85.
54. Meikle NB, Edlefsen LL, Lay JW. Suppression of tinnitus by bone conduction of ultrasound. Poster presented at the Twenty-First Annual Meeting of the Association for Research in Otolaryngology, 1999.
55. Weiler EWJ, Brill K, Tachiki K, Schneider D. Neurofeedback and quantitative electroencephalography. Int Tinnitus J 2002;8:87-93.